Hematogenous dissemination of glioblastoma multiforme

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Science Translational Medicine

• Publication date

  2014-07-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1126/scitranslmed.3009095PMID 25080476
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glioblastoma Multiforme: A Look Inside Its Heterogeneous Nature

  2014cited by this paper
• EGFRvIII gene rearrangement is an early event in glioblastoma tumorigenesis and expression defines a hierarchy modulated by epigenetic mechanisms

  2013cited by this paper
• Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.

  2013cited by this paper
• EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma.

  2013cited by this paper
• Dual Roles of the Transcription Factor Grainyhead-like 2 (GRHL2) in Breast Cancer*

  2013cited by this paper
• Overexpression of Evi‐1 oncoprotein represses TGF‐β signaling in colorectal cancer

  2013cited by this paper
• Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

  2013cited by this paper
• Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients

  2013cited by this paper
• Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer.

  2013cited by this paper
• Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.

  2013cited by this paper
• EVI1 splice variants modulate functional responses in ovarian cancer cells

  2013cited by this paper
• Metastatic glioblastoma: case presentations and a review of the literature

  2012cited by this paper
• Circulating tumor cells and circulating tumor DNA.

  2012cited by this paper
• Donor transmission of pineoblastoma in a two‐yr‐old male recipient of a multivisceral transplant: A case report

  2012cited by this paper
• Basic concepts in glioma immunology.

  2012cited by this paper
• Glioblastoma Stem–like Cell Lines with Either Maintenance or Loss of High-Level EGFR Amplification, Generated via Modulation of Ligand Concentration

  2012cited by this paper
• High‐resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer

  2012influential reference
• The Evi1, microRNA‐143, K‐Ras axis in colon cancer

  2011cited by this paper
• The Transcription Factor Evi-1 Is Overexpressed, Promotes Proliferation, and Is Prognostically Unfavorable in Infratentorial Ependymomas

  2011cited by this paper
• An extent of resection threshold for newly diagnosed glioblastomas.

  2011cited by this paper
• Rare phenomenon of extracranial metastasis of glioblastoma.

  2011cited by this paper
• Donor‐Transmitted Malignancies in Organ Transplantation: Assessment of Clinical Risk

  2011cited by this paper
• Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

  2011cited by this paper
• A distinct subset of glioma cell lines with stem cell‐like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target

  2011cited by this paper
• GFAP in health and disease.

  2011cited by this paper
• Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis.

  2010cited by this paper
• Survival of Patients with Newly Diagnosed Glioblastoma Treated with Radiation and Temozolomide in Research Studies in the United States

  2010cited by this paper
• Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1.

  2010cited by this paper
• Cancer esearch cular and Cellular Pathobiology ermal Growth Factor Receptor Expression Identifies ctionally and Molecularly Distinct Tumor-Initiating Cells uman Glioblastoma Multiforme and Is Required R Gliomagenesis

  2010cited by this paper
• The Sequence Alignment/Map format and SAMtools

  2009cited by this paper
• Identification of small gains and losses in single cells after whole genome amplification on tiling oligo arrays

  2009cited by this paper
• Intermediate-term outcome in lung transplantation from a donor with glioblastoma multiforme.

  2009cited by this paper
• Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.

  2009cited by this paper
• Transmission of glioblastoma multiforme after bilateral lung transplantation.

  2008cited by this paper
• Transmission of Metastatic Glioblastoma Multiforme From Donor to Lung Transplant Recipient

  2008cited by this paper
• Glial fibrillary acidic protein splice variants in hepatic stellate cells--expression and regulation.

  2008cited by this paper
• Smooth-muscle myosin mutations in hereditary non-polyposis colorectal cancer syndrome

  2008cited by this paper
• Colocalization of glial fibrillary acidic protein, metallothionein, and MHC II in human, rat, NOD/SCID, and nude mouse skin keratinocytes and fibroblasts.

  2007cited by this paper
• Serum GFAP is a diagnostic marker for glioblastoma multiforme.

  2007cited by this paper
• Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update.

  2007cited by this paper
• Molecular pathology of malignant gliomas.

  2006cited by this paper
• Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis.

  2006cited by this paper
• Karyotype analyses of 20 human glioma cell lines

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• A multiplex PCR predictor for aCGH success of FFPE samples

  2005cited by this paper
• Sequential application of interphase-FISH and CGH to single cells

  2005cited by this paper
• Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: case study and review of the literature.

  2004cited by this paper
• No evidence of tumour cells in blood of patients with glioma

  2003cited by this paper
• Immunocytochemical detection and characterization of individual micrometastatic tumor cells.

  2001cited by this paper
• Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969–2000)

  2000cited by this paper
• Primer3 on the WWW for general users and for biologist programmers.

  2000cited by this paper
• Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases.

  1998cited by this paper
• Transmission of tumours by transplantation.

  1998cited by this paper
• An explanation for the rarity of extraaxial metastases in brain tumors.

  1992cited by this paper
• Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

  1985cited by this paper
• Extraneural metastases of astrocytomas and glioblastomas clinicopathological study of two cases and review of literature

  1980cited by this paper
• The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature.

  1979cited by this paper
• [Extraneural metastasis of central nervous system tumours (author's transl)].

  1979cited by this paper
• In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

  1973cited by this paper
• BIOINFORMATICS ORIGINAL PAPER

  year unknowncited by this paper

• ASM-chip: an antibody-modified size-screening microfluidic chip for high-efficiency circulating glioma cell isolation and clinical application

  2026cites this paper
• Electron Accelerator-Enhanced Au Nanoclusters Electrochemiluminescence for Ultrasensitive Detection of Low-Expression Protein Based on DNA Hybridization Correctional Immunoreaction.

  2026cites this paper
• Liquid biopsies for the monitoring of gliomas and brain metastases in adults

  2025cites this paper
• Multidisciplinary treatment is necessary in glioblastoma with extracerebral metastases

  2025influential citation
• Recipient Outcomes After Utilization of Kidneys From Deceased Donors With Diagnosed Glioblastoma Multiforme

  2025cites this paper
• The Quest for Non-Invasive Diagnosis: A Review of Liquid Biopsy in Glioblastoma

  2025cites this paper
• Circulating tumor cells: Blood-based detection, molecular biology, and clinical applications

  2025cites this paper
• Circulating tumor cells as a recurrence risk marker in glioma: a retrospective study

  2025cites this paper
• Cancer neuroscience and glioma: clinical implications

  2025cites this paper
• Improved Diagnosis of Glioblastoma, IDH-Wildtype, Metastasis through Molecular and DNA Methylation Profiling: Two Case Reports

  2025cites this paper
• Challenges and Emerging Strategies of Immunotherapy for Glioblastoma

  2025cites this paper
• Regulation of the brain tumor microenvironment by focused ultrasound

  2025cites this paper
• Surface Charge Redistribution-Induced Electrochemiluminescence Enhancement of Gold Nanoclusters: The Novel Generation of Efficient Illuminants.

  2025cites this paper
• Extra-central nervous system metastasis from high-grade glioma: a single-institution experience

  2025cites this paper
• Circulating Tumor Cells in Glioblastoma

  2025cites this paper
• Extraneural metastases of glioblastoma: A case report and literature review

  2025cites this paper
• Microfluidic biosensors and devices for brain tumor diagnosis and monitoring.

  2025cites this paper
• Mechanisms and treatment of venous thromboembolism in patients with brain cancer: A narrative review.

  2025cites this paper
• Ataxin-2 as a candidate blood biomarker for estimating disease status in cases of suspected glioblastoma recurrence.

  2025cites this paper
• The establishment of organoids and their applications

  2025cites this paper
• Diffusely metastatic glioblastoma with FGFR3::TACC3 fusion: cell-free DNA fragmentation analyses and molecular characterization of matched primary and metastatic tumor sites

  2025cites this paper
• Microfluidic approaches for liquid biopsy in glioblastoma: Insights into diagnostic and follow‐up strategies

  2025cites this paper
• Liquid Biopsy as a Diagnostic and Monitoring Tool in Glioblastoma

  2025cites this paper
• Clinical, Radiological, and Molecular Insights into Extracranial Metastases from Adult Gliomas.

  2025cites this paper
• Immunoediting Dynamics in Glioblastoma: Implications for Immunotherapy Approaches

  2024cites this paper
• Serum liquid biopsy for brain tumours: a scoping analysis of practicable approaches in low- and middle-income countries.

  2024cites this paper
• A review of prognostic molecular biomarkers for glioblastoma and their clinical significance for diagnosis and treatment

  2024cites this paper
• Real-time viscoelastic deformability cytometry: High-throughput mechanical phenotyping of liquid and solid biopsies

  2024cites this paper
• Mesenchymal-type genetic mutations are likely pre-requisite for glioblastoma multiforme to metastasize outside the central nervous system: an original case series and systematic review of the literature.

  2024cites this paper
• Ultrahigh-Throughput, Real-Time Flow Cytometry for Rare Cell Quantification from Whole Blood.

  2024cites this paper
• Risk Factors for and Molecular Pathology Characteristics of Systemic Metastasis of Adult Cerebral Glioblastoma: A Pooled Individual Patient Data Analysis and Systematic Review

  2024cites this paper
• Liquid biopsy in cancer: current status, challenges and future prospects

  2024cites this paper
• A Synopsis of Biomarkers in Glioblastoma: Past and Present

  2024cites this paper
• Metastatic glioblastoma to the lungs: a case report and literature review

  2024cites this paper
• The anatomic basis of leptomeningeal metastasis

  2024cites this paper
• Principles in the Management of Glioblastoma

  2024cites this paper
• Evaluating circulating tumour cell enrichment techniques to establish an appropriate method for clinical application in glioblastomas

  2024cites this paper
• Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges

  2024cites this paper
• Use of circulating tumor cells and microemboli to predict diagnosis and prognosis in diffuse glioma.

  2024cites this paper
• Zonulin as Gatekeeper in Gut–Brain Axis: Dysregulation in Glioblastoma

  2024cites this paper
• Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy

  2024cites this paper
• Breaking boundaries: A rare case of glioblastoma with uncommon extraneural metastases: A case report and literature review

  2024cites this paper
• Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas

  2024cites this paper
• [Liquid biopsy in diagnosis of central nervous system tumors].

  2024cites this paper
• Cutaneous Seeding of Glioblastoma: A Case Report and Literature Review

  2024cites this paper
• Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors.

  2024cites this paper
• Circulating biomarkers in high-grade gliomas: current insights and future perspectives

  2024influential citation
• A New Systemic Disease Mouse Model for Glioblastoma Capable of Single-Tumour-Cell Detection

  2024cites this paper
• The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring

  2023cites this paper
• Extracranial metastasis of glioblastoma: A case report and literature review

  2023cites this paper
• Advances on Liquid Biopsy Analysis for Glioma Diagnosis

  2023cites this paper
• Innovative Approach to Isolate and Characterize Glioblastoma Circulating Tumor Cells and Correlation with Tumor Mutational Status

  2023cites this paper
• The Current Landscape of Glioblastoma Biomarkers in Body Fluids

  2023cites this paper
• Automated Capture and Analysis of Circulating Tumor Cells in Pediatric, Adolescent and Young Adult Patients with Central Nervous System Tumors

  2023cites this paper
• Disease Assessments in Patients with Glioblastoma

  2023cites this paper
• Models for evaluating glioblastoma invasion along white matter tracts.

  2023cites this paper
• A Rare Case of Glioblastoma with Osseous Metastases

  2023cites this paper
• Classification of Brain Tumors by Nanopore Sequencing of Cell-Free DNA from Cerebrospinal Fluid.

  2023cites this paper
• Circulating tumour cells for early detection of clinically relevant cancer

  2023cites this paper
• Recent advances in the use of liquid biopsy to fight central nervous system tumors.

  2023cites this paper
• Translational considerations for immunotherapy clinical trials in pediatric neuro-oncology

  2023cites this paper
• Development of DNA aptamers for visualization of glial brain tumors and detection of circulating tumor cells.

  2023cites this paper
• Imaging biomarkers for clinical applications in neuro-oncology: current status and future perspectives

  2023cites this paper
• Liquid biopsy and tumor DNA/RNA detection in the cerebrospinal fluid of patients diagnosed with central nervous system glioma – A review article

  2023cites this paper
• The coming of age of liquid biopsy in neuro-oncology

  2023cites this paper
• Liquid biomarkers in glioma

  2023influential citation
• Liquid biopsy and glioblastoma

  2023cites this paper
• Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience

  2023cites this paper
• The Impact of Survivorship Bias in Glioblastoma Research.

  2023cites this paper
• Transcriptomic analyses of patient peripheral blood with hemoglobin depletion reveal glioblastoma biomarkers

  2023cites this paper
• Electrostatic Interaction-Induced Aggregation-Induced Emission-Type AgAu Bimetallic Nanoclusters as a Highly Efficient Electrochemiluminescence Emitter for Ultrasensitive Detection of Glial Fibrillary Acidic Protein.

  2023cites this paper
• Circulating Tumor Cells and Thromboembolic Events in Patients with Glioblastoma

  2023cites this paper
• Profiling of circulating glial cells for accurate blood‐based diagnosis of glial malignancies

  2023cites this paper
• Liquid biopsy: creating opportunities in brain space

  2023cites this paper
• Gliosarcoma in a patient with triple-negative breast cancer: A case report

  2023cites this paper
• Extracranial metastasis of pediatric glioblastoma: case report and literature review

  2023cites this paper
• CSF Biopsy in Glioma: A Brief Review.

  2023cites this paper
• Recent Developments in Blood Biomarkers in Neuro-oncology

  2023cites this paper
• microRNAs (miRNAs) in Glioblastoma Multiforme (GBM)—Recent Literature Review

  2023cites this paper
• BRAF V600E-Mutant Glioblastoma with Extracranial Metastases Responsive to Combined BRAF and MEK Targeted Inhibition: A Case Report

  2022cites this paper
• Liquid biopsy for monitoring medulloblastoma

  2022cites this paper
• Case report: Fulminant extraneural metastasis of glioblastoma through venous sinus

  2022cites this paper
• A Case of Glioblastoma, Isocitrate Dehydrogenase Wild Type, With Widely Disseminated Osseous Metastasis

  2022cites this paper
• New perspectives in liquid biopsy for glioma patients

  2022cites this paper
• Nonhematogenic circulating aneuploid cells confer inferior prognosis and therapeutic resistance in gliomas

  2022cites this paper
• Primary bone destruction and extracranial metastases in an atypical glioblastoma with sarcomatoid features

  2022cites this paper
• Molecular Docking and Molecular Dynamics Studies Reveal Secretory Proteins as Novel Targets of Temozolomide in Glioblastoma Multiforme

  2022cites this paper
• Liquid Biopsy in Glioblastoma

  2022influential citation
• Detection of Circulating Glial Cells Enables Non-Invasive Diagnosis of Glial Malignancies

  2022cites this paper
• Detection of IDH1 Mutations in Plasma Using BEAMing Technology in Patients with Gliomas

  2022cites this paper
• Circulating Tumor Cells and Cell-free Tumor DNA in Evaluation and Management of Gliomas

  2022cites this paper
• A Novel Karyoplasmic Ratio-Based Automatic Recognition Method for Identifying Glioma Circulating Tumor Cells

  2022cites this paper
• Bone metastasis from glioblastoma: a systematic review

  2022cites this paper
• Single-Cell RNA Sequencing of Cerebrospinal Fluid as an Advanced Form of Liquid Biopsy for Neurological Disorders

  2022cites this paper
• Liquid biopsy in gliomas: a RANO review and proposals for clinical applications.

  2022cites this paper
• Metachronous Osseous Metastases From Gliobliostoma Mutiforme: An Unusual Presentation

  2022cites this paper
• Transtentorial spread of glioblastoma multiforme to cerebellopontine angle – A rare case report

  2022cites this paper
• Liquid biopsy: early and accurate diagnosis of brain tumor

  2022cites this paper
• The role of liquid biopsy in the diagnosis of glioblastoma progression

  2022cites this paper
• Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation

  2022cites this paper